Cardiology
Clinical
Triple therapy reduces exacerbations in patients with symptomatic COPD
Does triple therapy (long-acting beta2-agonist, long-acting muscarinic antagonist, and inhaled corticosteroid) reduce exacerbations in...
Clinical
HEART score can safely identify low risk chest pain
Clinical Question: Can the HEART score risk stratify emergency department patients with chest pain?
News
VIDEO: Clopidogrel bests ticagrelor in PCI for ACS in real-world study
BARCELONA – Fewer adverse events seen with less potent platelet inhibition in contemporary practice in CHANGE DAPT.
Video
VIDEO: Rivaroxaban plus aspirin cut cardiovascular events in stable patients
BARCELONA – The COMPASS trial produced “unambiguous results that should change guidelines and the management of stable coronary artery disease,”...
News
Forgo supplemental oxygen in adequately perfused patients with acute MI, study suggests
Supplemental oxygen shows no benefit in no-hypoxemia patients with acute MI.
Clinical
Rapid AMI rule out
Clinical Question: Can a single high-sensitivity cardiac troponin-T (hs-cTnT) reliably rule-out acute myocardial infarction (AMI) to safely enable...
News
Undiagnosed AF common in higher-risk patients
Patients at high risk of atrial fib and stroke commonly have undiagnosed AF.
News
Despite global decline, rheumatic heart disease persists in poorest regions
From 1990 to 2015, the percentage of deaths worldwide due to rheumatic heart disease rose in endemic regions of Oceania, South Asia, and central...
News
New findings from first all-female TAVR registry
PARIS – Preprocedural atrial fibrillation is associated with bad outcomes at 1 year.
News
FDA approves first spironolactone oral suspension
After more than 50 years on the U.S. market, spironolactone is available in liquid form, bypassing the compounding pharmacist.